SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001457612-21-000058
Filing Date
2021-04-29
Accepted
2021-04-29 07:13:27
Documents
17
Period of Report
2021-04-29
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K gnca-20210429.htm   iXBRL 8-K 35319
2 EX-99.1 a20210429ex-991.htm EX-99.1 50524
8 gnca-20210429_g1.jpg GRAPHIC 16581
9 image_01a.jpg GRAPHIC 63512
  Complete submission text file 0001457612-21-000058.txt   369108

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gnca-20210429.xsd EX-101.SCH 2462
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gnca-20210429_cal.xml EX-101.CAL 747
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gnca-20210429_def.xml EX-101.DEF 1693
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gnca-20210429_lab.xml EX-101.LAB 25298
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gnca-20210429_pre.xml EX-101.PRE 13227
10 EXTRACTED XBRL INSTANCE DOCUMENT gnca-20210429_htm.xml XML 10972
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Filer) CIK: 0001457612 (see all company filings)

IRS No.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36289 | Film No.: 21867052
SIC: 2836 Biological Products, (No Diagnostic Substances)